Overview
Experimental Medication For the Treatment of Generalized Anxiety Disorder
Status:
Completed
Completed
Trial end date:
2005-12-01
2005-12-01
Target enrollment:
0
0
Participant gender:
All
All
Summary
The purpose of this study is to determine whether an experimental anti-anxiety medication is effective in the treatment of Generalized Anxiety Disorder.Phase:
Phase 3Accepts Healthy Volunteers?
NoDetails
Lead Sponsor:
Jazz PharmaceuticalsTreatments:
Anti-Anxiety Agents
Criteria
Inclusion Criteria:- Subjects 18 to 65 years of age will be eligible to participate if they satisfy the
DSM-IV-TR criteria for the diagnosis of GAD.
Exclusion Criteria:
- No other primary psychiatric diagnosis besides GAD.